Risk factors
Precision Biosciences (DTIL) risk factors
Item 1A of every Precision Biosciences Inc. 10-K on file, and what changed from one year to the next.
- FY2025 10-K risk factors
73 risks, 5 new, 21 dropped, 18 reworded since the prior year. Precision BioSciences added regulatory risks covering UK clinical trials, US orphan drug designations, FDA Fast Track, and EU Health Technology Assessments.
Filed Mar 12, 2026 - FY2024 10-K risk factors
89 risks. Precision Biosciences faces substantial risks related to its ongoing operating losses, accumulated deficit of $482.5 million, and heavy reliance on the unproven ARCUS genome editing technology.
Filed Mar 26, 2025